Follow us on
Search News Archives
Conferences | Events
Lab Bulletin Media Partners
Concept Life Sciences

Concept Life Sciences

Concept Life Sciences

Products

Contact Concept Life Sciences


If you have not logged into the website then please enter your details below.

All articles from Concept Life Sciences

  Concept Life Sciences now offers polycyclic aromatic hydrocarbon testing service

Concept Life Sciences has added polycyclic aromatic hydrocarbon (PAH) analysis in edible oils to its range of ISO 17025 accredited services.

ConceptPAHs have been linked to a number of health issues including various forms of cancer, therefore, the food and allied industries have a responsibility to ensure product safety. The recently accredited service meets the demands of the edible oils industry for both food and pharmaceutical use and complies....

 

  Concept Life Sciences further strengthens its team with the appointment of Dr Andrew Clifton

Dr Andrew Clifton joins Concept Life Sciences as Head of Bioassay Development and Screening Technologies.

Concept Life Sciences offers tailored preclinical services including integrated drug discovery programs providing its international client base with world class integrated services....

 

  Concept Life Sciences strengthens bioanalytical and mechanistic toxicology expertise with the appointment of Dr Graeme Clark

Dr Graeme Clark PHD has joined Concept Life Sciences Dundee as Director of Analytical Services and DMPK.

Dr Graeme Clark PHDConcept Life Sciences offers tailored preclinical services in areas including investigative and mechanistic toxicology, exploratory and discovery toxicology, PK and metabolism and dermal absorption, as well as providing integrated drug discovery programs....

 

  Concept Life Sciences further expands its service offering by investing in Micro Chamber and Thermal Extraction Facilities

Concept Life Sciences has further expanded its analytical testing capabilities by making significant investment into Micro Chamber and Thermal Extraction facilities, used to sample VOCs or SVOCs emitted from products and materials.

Concept Life SciencesThe investment has been made to cope with the growing demand from both new and existing clients who insist on speedy, cost effective emissions screening and sampling of chemicals released from materials and products. Additionally, the new facilities will allow improved quality control as time consuming sample preparation is avoided...

 

  Peakdale Molecular Continues to Strengthen its Team Paving the Way for Further Growth

UK-based drug discovery services provider Peakdale Molecular (part of the Concept Life Sciences Group) has strengthened its sales and marketing team through the addition of a Head of Sales and Marketing.

Peakdale MolecularGordon Woodrow, BSc in Applied Microbiology, has been appointed Head of Sales and Marketing and joins Peakdale with over 25 years of commercial experience having held a number of senior positions in companies offering scientific services to the pharmaceutical and biotech industries. Prior to joining Peakdale Gordon was responsible for business development and strategic alliances at Proteros Biostructures. Whilst there Gordon played...

 

  Concept Life Sciences Makes its Fifth Acquisition Further Expanding its Analytical Support Services

Concept Life Sciences, scientific Laboratory and consultancy group has acquired pharmaceutical analytical testing business Agenda1 Analytical Services Ltd (Agenda 1).

Concept Life SciencesThis marks its fifth acquisition since it was formed in July 2014. Agenda 1 is a specialist contract analytical company delivering high quality analytical support to pharmaceutical, healthcare and medical device companies. Over the past year Concept Life Sciences has achieved an impressive organic growth rate and this deal is a prime example of how well-chosen partners can further expedite growth by extending capability. Agenda 1 was...

 

  Concept Life Sciences Acquires CXR Biosciences to Augment its Expanding Service Base in Discovery and PreClinical Sciences

Concept Life Sciences, scientific Laboratory and consultancy group has acquired CXR Biosciences.

CXR biosciencesThis marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life Sciences Group currently has over 600 staff in 11 core locations, with advanced plans for further expansion into continental Europe. CXR Biosciences is a leading investigative toxicology business. Its in-house expertise assists international life sciences companies to resolve issues relating to...

 

  Concept Life Sciences Appoints Matthew S Jones, Life Sciences Industry Leader, as Chief Commercial Officer

Concept Life Sciences, an international scientific laboratory and consultancy business, with a combined enterprise value approaching $100 million, has today announced the appointment of Matthew S. Jones as Chief Commercial Officer.

matthew jonesIn this role, Mr Jones will be responsible for leading Concepts’ global commercial organisation, which encompasses all sales, business development, marketing activities, and strategic partnering efforts. A veteran of the life sciences industry with almost two decades of experience, Jones joins Concept Life Sciences having transformed, led and driven commercial growth strategies for a diverse range of life science businesses both in Europe and the...

 

  Concept Life Sciences Creates a UK Based $100 Million Life Sciences Group with More Acquisitions Planned

Concept Life Sciences, a newly formed international scientific laboratory and consultancy business, has made three acquisitions with a combined enterprise value approaching $100 million.

The companies the group has acquired are Peakdale Molecular Limited, Resource & Environmental Consultants Limited and Scientific Analysis Laboratories Limited. Concept Life Sciences is led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan. Michael Fort has significant experience in the life sciences field having most recently held the position of Chief Executive Officer of Synexus Clinical Research where he worked for over 11 years. Michael has been involved in more than five M&A deals with a track record of building substantial value in the SME sector...